Skip to content
Dose Brief
Menu
No. 18 on the board · Grade B

Telos Rx review

The widest published catalog on our board (telosrx.com): compounded semaglutide and tirzepatide in oral and microdosed forms, plus intranasal NAD+, recovery peptides and bioidentical HRT — all compounded, none FDA-approved, on a LegitScript-certified platform.

Visit Telos Rx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$49/mo (microdosed, annual)
Tirzepatide
$99/mo (annual)
Coverage
Not publicly listed
Brand-name
Compounded only
On the trackerStableprice stableHeadline GLP tiers held flat this cycle, but the $49 microdosed and $99 tirzepatide rates are annual-lock prices — short-term plans run meaningfully higher, and everything outside GLP-1 stays unpriced until intake.

The scorecard

Telos Rx scored on our six Brief Score factors. See the methodology.

Price Stability84/100
Supply Reliability84/100
Transparency79/100
Access Breadth96/100
Clinical Oversight85/100
Track Record82/100

What we like

  • LegitScript-certified and HIPAA-compliant — a checkable trust signal most compounding desks lack
  • Deepest published menu we track — compounded semaglutide and tirzepatide alongside intranasal NAD+, recovery/GH peptides (sermorelin, ipamorelin, CJC-1295, BPC-157, TB-500) and bioidentical HRT
  • Genuinely needle-free options, including oral and microdosed tirzepatide, for the injection-averse
  • Low published GLP-1 entry — from ~$49/mo microdosed and ~$99/mo tirzepatide, with HSA/FSA accepted

The caveats

  • Every line is compounded and not FDA-approved — including the peptides, several of which are research-grade with thin human evidence
  • Pricing is opaque outside GLP-1, and the headline rates require a 6–12 month lock-in — short plans cost more
  • No named clinicians or leadership published, and only a thin base of public reviews
  • States served are not disclosed, so confirm your state before signing up

The brief

Best for: Readers who want GLP-1 care and a needle-free oral or microdosed route on the same certified desk that also carries peptides, NAD+ and HRT — and will trade FDA-approved brand access and up-front pricing for the deepest menu at the lowest annual-lock rate. The widest published catalog on our board (telosrx.com): compounded semaglutide and tirzepatide in oral and microdosed forms, plus intranasal NAD+, recovery peptides and bioidentical HRT — all compounded, none FDA-approved, on a LegitScript-certified platform.

Ranked #18 of 32 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 31 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Telos Rx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Telos Rx's site. Not medical advice; see our disclosure.

← Back to all rankings